High through anti-HBV drug screening by using reporter assay
使用报告基因检测进行高通量抗乙肝药物筛选
基本信息
- 批准号:19K08458
- 负责人:
- 金额:$ 2.83万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2019
- 资助国家:日本
- 起止时间:2019-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
项目成果
期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Durable response without recurrence to Tolvaptan improves long-term survival
托伐普坦的持久缓解且不复发可提高长期生存率
- DOI:10.1007/s00535-020-01721-8
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Nakai M;Suda G;Kubo A;Tokuchi Y;Kitagataya T;Yamada R;Shigesawa T;Suzuki K;Nakamura A;Kawagishi N;Ohara M;Umemura M;Sho T;Morikawa K;Ogawa K;Sakamoto N.
- 通讯作者:Sakamoto N.
FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma
- DOI:10.1080/15384047.2021.1939638
- 发表时间:2021-06
- 期刊:
- 影响因子:3.6
- 作者:Osamu Maehara;G. Suda;Mitsuteru Natsuizaka;T. Shigesawa;Gouki Kanbe;M. Kimura;M. Sugiyama;M. Mizokami;Masato Nakai;T. Sho;Kenichi Morikawa;Koji Ogawa;S. Ohashi;S. Kagawa;H. Kinugasa;S. Naganuma;N. Okubo;S. Ohnishi;Hiroshi Takeda;N. Sakamoto
- 通讯作者:Osamu Maehara;G. Suda;Mitsuteru Natsuizaka;T. Shigesawa;Gouki Kanbe;M. Kimura;M. Sugiyama;M. Mizokami;Masato Nakai;T. Sho;Kenichi Morikawa;Koji Ogawa;S. Ohashi;S. Kagawa;H. Kinugasa;S. Naganuma;N. Okubo;S. Ohnishi;Hiroshi Takeda;N. Sakamoto
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria
- DOI:10.1111/hepr.13693
- 发表时间:2021-07-20
- 期刊:
- 影响因子:4.2
- 作者:Sho, Takuya;Suda, Goki;Sakamoto, Naoya
- 通讯作者:Sakamoto, Naoya
Comparative Glycomic Analysis of Sialyl Linkage Isomers by Sialic Acid Linkage-Specific Alkylamidation in Combination with Stable Isotope Labeling of α2,3-Linked Sialic Acid Residues
- DOI:10.1021/acs.analchem.9b03617
- 发表时间:2019-11-05
- 期刊:
- 影响因子:7.4
- 作者:Hanamatsu, Hisatoshi;Nishikaze, Takashi;Sakamoto, Naoya
- 通讯作者:Sakamoto, Naoya
Overestimated Renal Function in Patients with Liver Cirrhosis Predicts Poor Prognosis
高估肝硬化患者的肾功能预示预后不良
- DOI:10.1111/hepr.13765
- 发表时间:2022
- 期刊:
- 影响因子:4.2
- 作者:Yoshida Sonoe;Suda Goki;et al.,
- 通讯作者:et al.,
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Suda Goki其他文献
Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases
Glecaprevir和Pibrentasvir治疗日本人类免疫缺陷病毒和基因3型丙型肝炎病毒合并感染患者:三例报告
- DOI:
10.2169/internalmedicine.1856-18 - 发表时间:
2019 - 期刊:
- 影响因子:1.2
- 作者:
Sho Takuya;Suda Goki;Kimura Megumi;Shimazaki Tomoe;Maehara Osamu;Shigesawa Taku;Suzuki Kazuharu;Nakamura Akihisa;Ohara Masatsugu;Umemura Machiko;Izumi Takaaki;Kawagishi Naoki;Baba Masaru;Nakai Masato;Natsuizaka Mitsuteru;Morikawa Kenichi;Ogawa Koji;Sakamo - 通讯作者:
Sakamo
臨床病態に基ずくアルコール性肝障害モデルの検討
基于临床病理的酒精性肝损伤模型检验
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Ohara Masatsugu;Ohnishi Shunsuke;Hosono Hidetaka;Yamamoto Koji;Yuyama Kohei;Nakamura Hideki;Fu Qingjie;Maehara Osamu;Suda Goki;Sakamoto Naoya;堀口昇男 - 通讯作者:
堀口昇男
日本血栓止血学会DIC診断基準2017年版の有用性の評価と新規予後予測マーカーの検索
日本血栓止血学会2017年版DIC诊断标准的实用性评价及寻找新的预后标志物
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Ogawa Koji;Kobayashi Takashi;Furukawa Jun-ichi;Hanamatsu Hisatoshi;Nakamura Akihisa;Suzuki Kazuharu;Kawagishi Naoki;Ohara Masatsugu;Umemura Machiko;Nakai Masato;Sho Takuya;Suda Goki;Morikawa Kenichi;Sakamoto Naoya et al.;Tetsuo Kobayashi;池添隆之 - 通讯作者:
池添隆之
腹水中のサイトカイン、マクロファージ解析からみた肝硬変の病態解析
从腹水中细胞因子和巨噬细胞分析肝硬化的病理学
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Kubo Akinori;Suda Goki;Kimura Megumi;Maehara Osamu;Tokuchi Yoshimasa;Kitagataya Takashi;Ohara Masatsugu;Yamada Ren;Shigesawa Taku;Suzuki Kazuharu;Kawagishi Naoki;Nakai Masato;Sho Takuya;Natsuizaka Mitsuteru;Morikawa Kenichi;Ogawa Koji;Ohnishi Shunsuke;Sak;田尻和人 - 通讯作者:
田尻和人
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis
预防性替诺福韦艾拉酚胺治疗乙型肝炎病毒再激活和再激活相关性肝炎
- DOI:
10.1002/jmv.28452 - 发表时间:
2023 - 期刊:
- 影响因子:12.7
- 作者:
Suda Goki;et al., - 通讯作者:
et al.,
Suda Goki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Hair follicle organoid model for drug screening
用于药物筛选的毛囊类器官模型
- 批准号:
23K13614 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a novel therapeutic strategy for angiosarcoma through drug screening
通过药物筛选开发血管肉瘤新治疗策略
- 批准号:
23K07757 - 财政年份:2023
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design of near-infrared and turn-on indicators for RNA-targeted drug screening
用于RNA靶向药物筛选的近红外和开启指示器的设计
- 批准号:
22H02099 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of novel drug screening system for neuroblastoma by elucidating the transcriptional activation mechanism of glycosyltransferase
阐明糖基转移酶转录激活机制,开发神经母细胞瘤新药筛选系统
- 批准号:
22K06593 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of Patient-Derived Organoids and Drug Screening for Cervical Cancer
患者源性类器官的建立和宫颈癌药物筛选
- 批准号:
22K16826 - 财政年份:2022
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Drug screening based on mouse replicating human atrial fibrillation phenotype
基于小鼠复制人类心房颤动表型的药物筛选
- 批准号:
21K19477 - 财政年份:2021
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of array silicon chips for construction of highly efficient drug screening systems
开发阵列硅芯片构建高效药物筛选系统
- 批准号:
20K15148 - 财政年份:2020
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Electrical characterization of renal proximal tubule epithelial cell on-a-chip for a nephrotoxic drug screening technology
用于肾毒性药物筛选技术的芯片上肾近曲小管上皮细胞的电学表征
- 批准号:
20K15311 - 财政年份:2020
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
To identify novel therapy drug of Drug induced gingival overgrowth targeting NR4A1 by drug screening
通过药物筛选寻找靶向NR4A1的药物性牙龈过度生长的新型治疗药物
- 批准号:
19K10130 - 财政年份:2019
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a next-generation patient-derived cancer model using chicken eggs and establishment of a drug screening method
使用鸡蛋开发下一代患者来源的癌症模型并建立药物筛选方法
- 批准号:
19K22689 - 财政年份:2019
- 资助金额:
$ 2.83万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)